Related references
Note: Only part of the references are listed.The Differential Diagnosis of Colitis in Endoscopic Biopsy Specimens A Review Article
Lisa A. Cerilli et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Association of Inflammatory Markers with Colorectal Cancer Incidence in the Atherosclerosis Risk in Communities Study
Anna E. Prizment et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Inflammatory Markers Are Associated With Risk of Colorectal Cancer and Chemopreventive Response to Anti-Inflammatory Drugs
Andrew T. Chan et al.
GASTROENTEROLOGY (2011)
Intestinal Inflammation and Cancer
Thomas A. Ullman et al.
GASTROENTEROLOGY (2011)
Circulating C-Reactive Protein Concentrations and Risks of Colon and Rectal Cancer: A Nested Case-Control Study Within the European Prospective Investigation into Cancer and Nutrition
Krasimira Aleksandrova et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)
Association between Change in Body Composition and Change in Inflammatory Markers: An 11-Year Follow-Up in the Whitehall II Study
Eleonor I. Fransson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
Kristine H. Allin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
Katriina Heikkilae et al.
CANCER CAUSES & CONTROL (2009)
The impact of dietary and lifestyle risk factors on risk of colorectal cancer: A quantitative overview of the epidemiological evidence
Rachel R. Huxley et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Kristine H. Allin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study
M. Henriksen et al.
GUT (2008)
C-reactive protein and colorectal cancer risk: A systematic review of prospective studies
Konstantinos K. Tsilidis et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Obesity and c-reactive protein levels among white, black, and hispanic US adults
Christina C. Wee et al.
OBESITY (2008)
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease
Marc S. Sabatine et al.
CIRCULATION (2007)
The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Catherine Dube et al.
ANNALS OF INTERNAL MEDICINE (2007)
Carcinogenesis in inflammatory bowel disease
Laszlo Herszenyi et al.
DIGESTIVE DISEASES (2007)
Oratory markers in IBD: Magic, or unneccessary toys?
S Vermeire et al.
GUT (2006)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Bowel inflammation as measured by fecal calprotectin: A link between lifestyle factors and colorectal cancer risk
A Poullis et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers
LC Hudgins et al.
JOURNAL OF LIPID RESEARCH (2003)
Population distributions of C-reactive protein in apparently healthy men and women in the United States: Implication for clinical interpretation
N Rifai et al.
CLINICAL CHEMISTRY (2003)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Share Paper
